Significato clinico della risonanza magnetica e correlazioni ecocardiografiche nella valutazione della cardiomiopatia ipertrofica.

Translated title of the contribution: Clinical significance of magnetic resonance and echocardiographic correlations in the evaluation of hypertrophic cardiomyopathy

R. Fattori, C. Rapezzi, F. Castriota, G. Magnani, P. Bertaccini, N. Galiè, B. Magnani, G. Gavelli

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Relatively few clinical studies have investigated the role of MRI in the patients with hypertrophic cardiomyopathy. To assess MR capabilities in defining the presence, distribution and severity of left ventricular hypertrophy, the prevalence and clinical correlations of right ventricular hypertrophy and the prevalence and clinical implications of structural myocardial abnormalities, MRI and echocardiography were performed on 37 unselected patients with hypertrophic cardiomyopathy. The two methods were in agreement in 100% of cases in diagnosing the disease and classifying left ventricular hypertrophy as asymmetric, concentric or apical, and in 92% of cases in assessing the topographic distribution of hypertrophy of ventricular segments. A statistically significant linear correlation was found between echocardiographic and MR measurements of interventricular septum (r = 0.69, p <0.0001, SEE = 4) and left posterior wall of the left ventricle (r = 0.67, p <0.0001, SEE = 2.4). Right ventricular hypertrophy (right anterior wall diastolic thickness > 5 mm) was demonstrated by MRI in 23 of 33 patients (70%). In this group, left posterior wall thickness and left atrial diameter were higher (15 +/- 4 vs 11 +/- 2, p <0.01 and 45 +/- 9 vs 38 +/- 5 mm, p <0.05, respectively). On T2-weighted sequences, areas of reduced signal intensity, probably due to myocardial fibrosis, were detected in 16 cases (43%). This group was characterized by higher max. septal thickness (25 +/- 7 vs 21 +/- 6 mm, p <0.05) and max. left posterior wall thickness (15 +/- 9 vs 7 +/- 8 mm, p <0.05). All the three cases with dilated and hypokinetic left ventricle showed this kind of tissue abnormality. In conclusion, MRI provided clear, accurate and exhaustive data on the presence and distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. Right ventricular hypertrophy and structural abnormalities of ventricular myocardium can also be detected and quantified. Right ventricular involvement is associated with more severe hypertrophy of left ventricular posterior wall. Structural myocardial abnormalities, probably due to fibrosis, are related to the extent of left ventricular hypertrophy.

Original languageItalian
Pages (from-to)36-43
Number of pages8
JournalRadiologia Medica
Volume88
Issue number1-2
Publication statusPublished - Jul 1994

Fingerprint

Hypertrophic Cardiomyopathy
Left Ventricular Hypertrophy
Magnetic Resonance Spectroscopy
Right Ventricular Hypertrophy
Fibrosis
Hypertrophy
Heart Ventricles
Echocardiography
Myocardium

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Fattori, R., Rapezzi, C., Castriota, F., Magnani, G., Bertaccini, P., Galiè, N., ... Gavelli, G. (1994). Significato clinico della risonanza magnetica e correlazioni ecocardiografiche nella valutazione della cardiomiopatia ipertrofica. Radiologia Medica, 88(1-2), 36-43.

Significato clinico della risonanza magnetica e correlazioni ecocardiografiche nella valutazione della cardiomiopatia ipertrofica. / Fattori, R.; Rapezzi, C.; Castriota, F.; Magnani, G.; Bertaccini, P.; Galiè, N.; Magnani, B.; Gavelli, G.

In: Radiologia Medica, Vol. 88, No. 1-2, 07.1994, p. 36-43.

Research output: Contribution to journalArticle

Fattori, R, Rapezzi, C, Castriota, F, Magnani, G, Bertaccini, P, Galiè, N, Magnani, B & Gavelli, G 1994, 'Significato clinico della risonanza magnetica e correlazioni ecocardiografiche nella valutazione della cardiomiopatia ipertrofica.', Radiologia Medica, vol. 88, no. 1-2, pp. 36-43.
Fattori R, Rapezzi C, Castriota F, Magnani G, Bertaccini P, Galiè N et al. Significato clinico della risonanza magnetica e correlazioni ecocardiografiche nella valutazione della cardiomiopatia ipertrofica. Radiologia Medica. 1994 Jul;88(1-2):36-43.
Fattori, R. ; Rapezzi, C. ; Castriota, F. ; Magnani, G. ; Bertaccini, P. ; Galiè, N. ; Magnani, B. ; Gavelli, G. / Significato clinico della risonanza magnetica e correlazioni ecocardiografiche nella valutazione della cardiomiopatia ipertrofica. In: Radiologia Medica. 1994 ; Vol. 88, No. 1-2. pp. 36-43.
@article{fc694d87617c48e29edeca9d32feb7b1,
title = "Significato clinico della risonanza magnetica e correlazioni ecocardiografiche nella valutazione della cardiomiopatia ipertrofica.",
abstract = "Relatively few clinical studies have investigated the role of MRI in the patients with hypertrophic cardiomyopathy. To assess MR capabilities in defining the presence, distribution and severity of left ventricular hypertrophy, the prevalence and clinical correlations of right ventricular hypertrophy and the prevalence and clinical implications of structural myocardial abnormalities, MRI and echocardiography were performed on 37 unselected patients with hypertrophic cardiomyopathy. The two methods were in agreement in 100{\%} of cases in diagnosing the disease and classifying left ventricular hypertrophy as asymmetric, concentric or apical, and in 92{\%} of cases in assessing the topographic distribution of hypertrophy of ventricular segments. A statistically significant linear correlation was found between echocardiographic and MR measurements of interventricular septum (r = 0.69, p <0.0001, SEE = 4) and left posterior wall of the left ventricle (r = 0.67, p <0.0001, SEE = 2.4). Right ventricular hypertrophy (right anterior wall diastolic thickness > 5 mm) was demonstrated by MRI in 23 of 33 patients (70{\%}). In this group, left posterior wall thickness and left atrial diameter were higher (15 +/- 4 vs 11 +/- 2, p <0.01 and 45 +/- 9 vs 38 +/- 5 mm, p <0.05, respectively). On T2-weighted sequences, areas of reduced signal intensity, probably due to myocardial fibrosis, were detected in 16 cases (43{\%}). This group was characterized by higher max. septal thickness (25 +/- 7 vs 21 +/- 6 mm, p <0.05) and max. left posterior wall thickness (15 +/- 9 vs 7 +/- 8 mm, p <0.05). All the three cases with dilated and hypokinetic left ventricle showed this kind of tissue abnormality. In conclusion, MRI provided clear, accurate and exhaustive data on the presence and distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. Right ventricular hypertrophy and structural abnormalities of ventricular myocardium can also be detected and quantified. Right ventricular involvement is associated with more severe hypertrophy of left ventricular posterior wall. Structural myocardial abnormalities, probably due to fibrosis, are related to the extent of left ventricular hypertrophy.",
author = "R. Fattori and C. Rapezzi and F. Castriota and G. Magnani and P. Bertaccini and N. Gali{\`e} and B. Magnani and G. Gavelli",
year = "1994",
month = "7",
language = "Italian",
volume = "88",
pages = "36--43",
journal = "Radiologia Medica",
issn = "0033-8362",
publisher = "Springer-Verlag Italia s.r.l.",
number = "1-2",

}

TY - JOUR

T1 - Significato clinico della risonanza magnetica e correlazioni ecocardiografiche nella valutazione della cardiomiopatia ipertrofica.

AU - Fattori, R.

AU - Rapezzi, C.

AU - Castriota, F.

AU - Magnani, G.

AU - Bertaccini, P.

AU - Galiè, N.

AU - Magnani, B.

AU - Gavelli, G.

PY - 1994/7

Y1 - 1994/7

N2 - Relatively few clinical studies have investigated the role of MRI in the patients with hypertrophic cardiomyopathy. To assess MR capabilities in defining the presence, distribution and severity of left ventricular hypertrophy, the prevalence and clinical correlations of right ventricular hypertrophy and the prevalence and clinical implications of structural myocardial abnormalities, MRI and echocardiography were performed on 37 unselected patients with hypertrophic cardiomyopathy. The two methods were in agreement in 100% of cases in diagnosing the disease and classifying left ventricular hypertrophy as asymmetric, concentric or apical, and in 92% of cases in assessing the topographic distribution of hypertrophy of ventricular segments. A statistically significant linear correlation was found between echocardiographic and MR measurements of interventricular septum (r = 0.69, p <0.0001, SEE = 4) and left posterior wall of the left ventricle (r = 0.67, p <0.0001, SEE = 2.4). Right ventricular hypertrophy (right anterior wall diastolic thickness > 5 mm) was demonstrated by MRI in 23 of 33 patients (70%). In this group, left posterior wall thickness and left atrial diameter were higher (15 +/- 4 vs 11 +/- 2, p <0.01 and 45 +/- 9 vs 38 +/- 5 mm, p <0.05, respectively). On T2-weighted sequences, areas of reduced signal intensity, probably due to myocardial fibrosis, were detected in 16 cases (43%). This group was characterized by higher max. septal thickness (25 +/- 7 vs 21 +/- 6 mm, p <0.05) and max. left posterior wall thickness (15 +/- 9 vs 7 +/- 8 mm, p <0.05). All the three cases with dilated and hypokinetic left ventricle showed this kind of tissue abnormality. In conclusion, MRI provided clear, accurate and exhaustive data on the presence and distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. Right ventricular hypertrophy and structural abnormalities of ventricular myocardium can also be detected and quantified. Right ventricular involvement is associated with more severe hypertrophy of left ventricular posterior wall. Structural myocardial abnormalities, probably due to fibrosis, are related to the extent of left ventricular hypertrophy.

AB - Relatively few clinical studies have investigated the role of MRI in the patients with hypertrophic cardiomyopathy. To assess MR capabilities in defining the presence, distribution and severity of left ventricular hypertrophy, the prevalence and clinical correlations of right ventricular hypertrophy and the prevalence and clinical implications of structural myocardial abnormalities, MRI and echocardiography were performed on 37 unselected patients with hypertrophic cardiomyopathy. The two methods were in agreement in 100% of cases in diagnosing the disease and classifying left ventricular hypertrophy as asymmetric, concentric or apical, and in 92% of cases in assessing the topographic distribution of hypertrophy of ventricular segments. A statistically significant linear correlation was found between echocardiographic and MR measurements of interventricular septum (r = 0.69, p <0.0001, SEE = 4) and left posterior wall of the left ventricle (r = 0.67, p <0.0001, SEE = 2.4). Right ventricular hypertrophy (right anterior wall diastolic thickness > 5 mm) was demonstrated by MRI in 23 of 33 patients (70%). In this group, left posterior wall thickness and left atrial diameter were higher (15 +/- 4 vs 11 +/- 2, p <0.01 and 45 +/- 9 vs 38 +/- 5 mm, p <0.05, respectively). On T2-weighted sequences, areas of reduced signal intensity, probably due to myocardial fibrosis, were detected in 16 cases (43%). This group was characterized by higher max. septal thickness (25 +/- 7 vs 21 +/- 6 mm, p <0.05) and max. left posterior wall thickness (15 +/- 9 vs 7 +/- 8 mm, p <0.05). All the three cases with dilated and hypokinetic left ventricle showed this kind of tissue abnormality. In conclusion, MRI provided clear, accurate and exhaustive data on the presence and distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. Right ventricular hypertrophy and structural abnormalities of ventricular myocardium can also be detected and quantified. Right ventricular involvement is associated with more severe hypertrophy of left ventricular posterior wall. Structural myocardial abnormalities, probably due to fibrosis, are related to the extent of left ventricular hypertrophy.

UR - http://www.scopus.com/inward/record.url?scp=0028470357&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028470357&partnerID=8YFLogxK

M3 - Articolo

VL - 88

SP - 36

EP - 43

JO - Radiologia Medica

JF - Radiologia Medica

SN - 0033-8362

IS - 1-2

ER -